Dr. Margaret von Mehren, MD
Claim this profileFox Chase Cancer Center
Area of expertise
Soft Tissue Sarcoma
Margaret von Mehren, MD has run 5 trials for Soft Tissue Sarcoma. Some of their research focus areas include:
Cancer
Margaret von Mehren, MD has run 5 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Fox Chase Cancer Center
Temple University - Fox Chase Cancer Center
Clinical Trials Margaret von Mehren, MD is currently running
DCC-3116 + Anticancer Therapies
for Advanced Cancers
This is a Phase 1/2, multicenter, open-label (unless otherwise specified in a combination-specific module) study of inlexisertib in combination with anticancer therapies. Modules within the master protocol are defined according to different combinations of inlexisertib with other anticancer agents.
Recruiting
1 award
Phase 1 & 2
Targeted Therapy
for Advanced Stage Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting
1 award
Phase 2
9 criteria
More about Margaret von Mehren, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Margaret von Mehren, MD has experience with
- Cyclophosphamide
- Everolimus
- Ribociclib
- Doxorubicin
- Doxil
- Fludarabine
Breakdown of trials Margaret von Mehren, MD has run
Soft Tissue Sarcoma
Cancer
Liposarcoma
Round Cell Liposarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margaret von Mehren, MD specialize in?
Margaret von Mehren, MD focuses on Soft Tissue Sarcoma and Cancer. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Margaret von Mehren, MD currently recruiting for clinical trials?
Yes, Margaret von Mehren, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Margaret von Mehren, MD has studied deeply?
Yes, Margaret von Mehren, MD has studied treatments such as Cyclophosphamide, Everolimus, Ribociclib.
What is the best way to schedule an appointment with Margaret von Mehren, MD?
Apply for one of the trials that Margaret von Mehren, MD is conducting.
What is the office address of Margaret von Mehren, MD?
The office of Margaret von Mehren, MD is located at: Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 United States. This is the address for their practice at the Fox Chase Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.